Jefferies Financial Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Jefferies Financial Group's CRL Position: Q3 2026 in Review
Jefferies Financial Group reduced its Charles River Laboratories (CRL) stake by 45% in Q3 2026, selling an estimated $2.15M and leaving 10,121 shares worth $2.99M. The position accounts for 0.02% of the portfolio, ranked #432.
Jefferies Financial Group first reported a position in CRL in Q3 2023 and has held it in 9 quarters since. The position peaked at $4.14M in Q2 2026. 642 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Jefferies Financial Group held 10,121 shares of Charles River Laboratories worth $2.99M as of Q3 2026.
- Jefferies Financial Group sold 8,149 Charles River Laboratories shares in Q3 2026, an estimated $2.15M.
- Charles River Laboratories made up 0.02% of Jefferies Financial Group's portfolio in Q3 2026, its #432 holding.
- Jefferies Financial Group first reported a position in Charles River Laboratories in Q3 2023 and has held it in 9 quarters since.
- Jefferies Financial Group's Charles River Laboratories position peaked at $4.14M in Q2 2026.
- 642 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.